Invention Grant
- Patent Title: End-tidal carbon dioxide and amplitude spectral area as non-invasive markers of coronary perfusion pressure
-
Application No.: US15420653Application Date: 2017-01-31
-
Publication No.: US09949686B2Publication Date: 2018-04-24
- Inventor: Keith G. Lurie
- Applicant: ResQSystems, Inc.
- Applicant Address: US MA Chelmsford
- Assignee: ZOLL MEDICAL CORPORATION
- Current Assignee: ZOLL MEDICAL CORPORATION
- Current Assignee Address: US MA Chelmsford
- Agency: The Webb Law Firm
- Main IPC: A61N1/00
- IPC: A61N1/00 ; A61B5/00 ; A61H31/00 ; A61B5/08 ; A61B5/0402 ; A61N1/39
Abstract:
End-tidal carbon dioxide (ETCO2) measurements may be used alone as a guide to determine when to defibrillate an individual. Alternatively, ETCO2 measurements may be used in combination with amplitude spectral area measurements as a guide to determine when to defibrillate an individual.
Public/Granted literature
Information query
